Cancer Vaccines
NovaRx To Present Lucanix Phase II Clinical Data at ASCO
Published in Medicine and Law Weekly, June 15th, 2007
NovaRx Corporation announced today that data from the Company's Phase II clinical trial treating individuals with advanced stages of non-small cell lung cancer ("NSCLC") will be presented on June 4, 2006, at the American Society of Clinical Oncology ("ASCO") meeting in Atlanta, GA. The Phase II study was designed to determine the safety and efficacy of Lucanix(tm), a novel therapeutic treatment under development by NovaRx. In contrast to conventional cancer therapies, where systemic chemotherapeutic drugs nonspecifically kill the tumor and normal cells, the therapeutic vaccine developed by NovaRx specifically induces the patient's immune system to attack the tumor. In clinical studies to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Female Infertility
Data from National University of Singapore provide new insights into female infertility - Glaucoma
Scientists at University of Zurich, Department of Ophthalmology publish new data on glaucoma - Health Policy
Researchers from Centers for Disease Control and Prevention describe findings in health policy - Psychoactive Drugs
Researchers at Temple University have published new data on psychoactive drugs - Schizophrenia Therapy
Data from Karolinska Institute advance knowledge in schizophrenia therapy - Adverse Drug Reactions
Drug Safety Alliance Adopts Phase Forward's Newest Web-Based Clintrace Solution - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
